Glipizide

Product NDC: 50090-3069
11-digit product format: 500903069
Labeler code: 50090
Product ID: 50090-3069_53cc167c-3ad0-4afe-96a4-cbf6994184a1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glipizide
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA076159
Marketing category: ANDA
Marketing start: 2016-12-21
Marketing end: 0000-00-00
Substance: GLIPIZIDE
Active strength: 5 mg/1
Pharmacologic classes: Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50090-3069		I	Inactivated by FDA	2026-08-17
excluded package	package	50090-3069	50090-3069-0	D	Discontinued by firm	2026-08-17
excluded package	package	50090-3069	50090-3069-2	I	Inactivated by FDA	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-3069-0	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-3069-2	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-3069-0	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-3069-2	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-3069-0	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-3069-2	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-3069-0	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-3069-2	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-3069-0	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-3069-2	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-3069-0	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-3069-2	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-3069-0	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-3069-2	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-3069-0	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-3069-2	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-3069-0	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-3069-2	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-3069-0	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-3069-2	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-3069-0	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-3069-2	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-3069-0	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-3069-2	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-3069-2	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-3069-2	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-3069-2	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A076159-001	GLIPIZIDE	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL			2013-09-20
A076159-002	GLIPIZIDE	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL			2013-09-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL	AB	2013-09-20	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL	AB	2013-09-20	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A076159-001	GLIPIZIDE	10MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A076159-002	GLIPIZIDE	5MG	TABLET, EXTENDED RELEASE / ORAL		2013-09-20	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A076159-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A076159-002	AB	1	`74a2ff9319b5…`
2021-12-28 21:50 UTC	2021-12	A076159-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A076159-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076159-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A076159-002	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A076159-001	AB	1	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	A076159-002	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A076159-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A076159-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A076159-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A076159-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A076159-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A076159-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A076159-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A076159-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A076159-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A076159-002	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09	Product name	2	20250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5	Product name	5	20180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776a	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-3069-0	2023-01-30	C162847	48780-1	f386c649-dab0-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use GLIPIZIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for GLIPIZIDE EXTENDED-RELEASE TABLETS. GlipiZIDE Extended-Release Tablets, for oral use Initial U.S. Approval: 1994
50090-3069-2	2023-01-30	C162847	48780-1	f386c649-dab0-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use GLIPIZIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for GLIPIZIDE EXTENDED-RELEASE TABLETS. GlipiZIDE Extended-Release Tablets, for oral use Initial U.S. Approval: 1994

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-3069-0	Glipizide	30 in 1 BOTTLE	TABLET, FILM COATED, EXTENDED RE	30		10
50090-3069-2	Glipizide	90 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED, EXTENDED RE	90		10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-3069-0	EA - Each	50090-3069	15b07696-5027-43ff-8837-8797225d399c	1	2019-02-13
50090-3069-2	EA - Each	50090-3069	f8cc4257-a3a1-46f8-8347-c7e42ceef9a1	1	2019-05-02

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-3069	GLIPIZIDE TABLET, FILM COATED, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS]	10	Legacy NDC, 2 package rows	20200219_98591ff5-b735-47b0-9bd2-1e9118d261e6.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X7WDT95N5C	GLIPIZIDE	29094-61-9	GLIPIZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
315107	glipiZIDE 10 MG 24HR Extended Release Oral Tablet	PSN	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
314006	glipiZIDE 5 MG 24HR Extended Release Oral Tablet	PSN	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
315107	24 HR glipizide 10 MG Extended Release Oral Tablet	SCD	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
314006	24 HR glipizide 5 MG Extended Release Oral Tablet	SCD	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
315107	glipizide ER 10 MG 24 HR Extended Release Oral Tablet	SY	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
314006	glipizide ER 5 MG 24 HR Extended Release Oral Tablet	SY	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
315107	glipizide XL 10 MG 24 HR Extended Release Oral Tablet	SY	98591ff5-b735-47b0-9bd2-1e9118d261e6	10
314006	glipizide XL 5 MG 24 HR Extended Release Oral Tablet	SY	98591ff5-b735-47b0-9bd2-1e9118d261e6	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-3069-0	50090306900	30 in 1 BOTTLE					Historical
50090-3069-2	50090306902	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50090-3069-2)	2016-12-21	0000-00-00	No	No	Current